Lyroxen CR 165 mg (Tablet (Controlled Release))

Title

• Lyroxen CR 165 mg Tablet

Categories

• Neuropathic pain medication
• Anti-epileptic drugs
• Fibromyalgia treatment

Description

• First-line treatment for neurotic pain, shingles, seizures, and fibromyalgia
• Taken orally with or without food
• Contraindicated in patients with known hypersensitivity to Pregabalin or any of its components

Dimensions

• Tablet

Color options

Functions

• Pain relief
• Seizure management

Materials

Technical specifications

• Molecular Formula: C8H17NO2

Design elements

Usability features

• Swallowed whole
• Not split, crushed or chewed
• Gradual tapering when discontinuing

Dosage instructions

• Neuropathic pain associated with diabetic peripheral neuropathy in adults (DPN):
  • Maximum recommended dose of 100 mg three times a day
  • Dose may be increased to 300 mg/day based on efficacy and tolerability
• Postherpetic neuralgia in adults (PHN):
  • Recommended dose of 75 to 150 mg two times a day or 50 to 100 mg three times a day
  • Maximum recommended dose is 300 mg/day
• Management of fibromyalgia in adults:
  • Recommended dose of 300 to 450 mg/day
  • Dose may be increased based on efficacy and tolerability
• Neuropathic pain associated with spinal cord injury in adults:
  • Recommended dose range of 150 to 600 mg/day
  • Dose may be increased based on efficacy and tolerability
• Conversion from Pregabalin capsules to Pregabalin CR capsule tablet:
  • Specific instructions provided for transitioning between dosages

Interaction information

• Unlikely to be involved in significant pharmacokinetic drug interactions
• No significant drug interaction with food and others

Contraindications

• Known hypersensitivity to Pregabalin or any of its components

Side effects

• Dizziness
• Somnolence
• Dry mouth
• Edema
• Blurred vision
• Weight gain
• Difficulty with concentration/attention

Pregnancy lactation info

• Pregnancy:
  • Potential risk to fetus
  • No well-controlled studies in pregnant women
• Lactation:
  • Small amounts detected in the milk of lactating women
  • Breastfeeding not recommended due to potential risk of tumorigenicity

Precautions warnings

• Angioedema
• Hypersensitivity reactions
• Risk of suicidal thoughts or behavior
• Respiratory depression
• May impair ability to drive or operate machinery
• Increased seizure frequency if rapidly discontinued

Age restrictions

• Use in children and adolescents:
  • Safety and effectiveness not established for various conditions in pediatric patients
  • Not established for pediatric patients below the age of 1 month

Overdose effects

• Reduced consciousness
• Depression/anxiety
• Confusional state
• Seizures
• Heart block
• No specific antidote available

Therapeutic class

• Adjunct anti-epileptic drugs
• Primary anti-epileptic drugs

Storage conditions

• Keep in cool & dry place (below 30°C)
• Protected from light & moisture
• Keep out of the reach of children

Common questions

• What is Lyroxen CR 165 mg CR Tablet?: First-line treatment for neurotic pain, shingles, seizures and fibromyalgia
• How long do I need to use Lyroxen CR 165 mg CR Tablet before I see improvement in my condition?: Take till improvement is seen
• At what frequency do I need to use Lyroxen CR 165 mg CR Tablet?: As prescribed by the doctor
• Should I use Lyroxen CR 165 mg CR Tablet empty stomach, before food or after food?: After food as prescribed
• What are the instructions for the storage and disposal of Lyroxen CR 165 mg CR Tablet?: Keep in a cool dry place and in its original packaging

Related Brands

• Lyroxen CR 82.5 mg (Tablet (Controlled Release)) - everest-pharmaceuticals-ltd
• Pregaben CR 165 mg (Tablet (Controlled Release)) - incepta-pharmaceuticals-ltd
• Pregaben CR 82.5 mg (Tablet (Controlled Release)) - incepta-pharmaceuticals-ltd
• Nerfid 150 mg (Capsule) - the-white-horse-pharmaceuticals-ltd
• Nerfid 25 mg (Capsule) - the-white-horse-pharmaceuticals-ltd